Jayly Jermayne Jackson, | |
3801 University Lake Dr Ste 205, Anchorage, AK 99508-4658 | |
(907) 729-2492 | |
(907) 729-3950 |
Full Name | Jayly Jermayne Jackson |
---|---|
Gender | Male |
Speciality | Community Health Worker |
Location | 3801 University Lake Dr Ste 205, Anchorage, Alaska |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1114698818 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
101YM0800X | Counselor - Mental Health | (* (Not Available)) | Secondary |
172V00000X | Community Health Worker | (* (Not Available)) | Primary |
Mailing Address | Practice Location Address |
---|---|
Jayly Jermayne Jackson, 3801 University Lake Dr, Anchorage, AK 99508-4658 Ph: (907) 729-2492 | Jayly Jermayne Jackson, 3801 University Lake Dr Ste 205, Anchorage, AK 99508-4658 Ph: (907) 729-2492 |
News Archive
Dr. Maurizio D'Incalci, MD, Ph.D., will receive an award in recognition of his scientific career at the new Special Conference on Anticancer Drug Action and Drug Resistance: from Cancer Biology to the Clinic organized by the European Association of Cancer Research, the American Association of Cancer Research and the Italian Cancer Society and that will be held in Florence, Italy, June 20-23.
Accumulating evidence suggests that rates of low bone mass are greater in HIV-infected males than in females. Researchers led by Grace Aldrovandi, MD, chief of the Division of Infectious Diseases at Children's Hospital Los Angeles, studied 11 biomarkers associated with inflammation, bone loss and/or bone formation in about 450 individuals - assessed by sex and HIV status - to try to determine causes of this differential bone loss.
BioBehavioral Diagnostics (BioBDx), a privately held company which manufactures and markets the Quotientâ„¢ ADHD System, a tool that aids in the objective and accurate assessment of attention-deficit hyperactivity disorder (ADHD), announced today the first close of a $10 million Series B financing.
The U.S. Department of Defense is funding the first human trial of a device to speed up and enhance the natural system of brain cleansing that occurs when we sleep.
In 2006, researchers published a widely reported study showing that for many patients who had suffered a heart attack more than 24 hours before and had a blocked coronary artery, certain heart procedures, such as balloon angioplasty and the insertion of stents, were no more effective than drugs alone. In 2007, the American Heart Association and the American College of Cardiology issued guidelines urging doctors to not use such treatments in those patients.
› Verified 9 days ago